DOCSLIB.ORG

List of Controlled Drugs and Permitted Quantities)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Controlled Drugs and Permitted Quantities) 1.6 Open General Licence List (List of controlled drugs and permitted quantities) The following are the maximum quantities which may be carried by patients without requiring a licence, provided they carry with them a covering letter from their prescribing doctor. Alphapropine 3600mgs Amphetamine 300mgs Amphetamine Phosphate 225mgs Amphetamine Sulphate 225mgs Anhydrous Morphine 360mgs Anileridine 900mgs Anileridine Hydrochloride 900mgs Anileridine Phosphate 900mgs Benzphetamine 2250mgs Benzitramine 450mgs Buprenorphine (as hydrochloride) Temgesic 24mg Buprenorphine (as hydrochloride) Subutex 140mg Chlorphentermine Hydrochloride 975mgs Cocaine Hydrochloride, Nitrate, or ) 20ml at 4% 4mlSulphate Eyedrops ) maximum strength Cocaine Hydrochloride, Nitrate, or Sulphate ) as active ingredient in a mixture being used ) 500mgs by a patient who is terminally ill. ) Dexamphetamine 300mgs Dexamphetamine Phosphate 150mgs Dexamphetamine Sulphate 900mgs Dextromoramide Tartrate 900mgs Diamorphine Hydrochloride as an ingredient 500mgs ) Permission in a mixture or linctus ) will be needed ) from relevant ) Ministry of Diamorphine Hydrochloride Tablets 450mgs ) Health as Diamorphine Hydrochloride Ampoules 1350mgs ) Diamorphine Diamorphine Hydrochloride Elixir 500mgs ) is illegal in )most of the )world. Diazepam (and all drugs falling within Schedule 4 Part II) 900mgs Diethylpropion Hydrochloride 1125mgs 1 Dihydrocodeine Tartrate 3600mgs ) Not controlled Dihydrcodeine O-carboxymethyloxine 150mgs ) if not injectable ) or tablet strength <100mg Dipipanone 600mgs Drotebanol 15000mgs Ethinamate 15000mgs Fentanyl Citrate 45mgs / 4500mcg Rohypnol/Flunitrazepam 30mgs Glutethimide 7500mgs Hydrocodone Hydrochloride 675mgs Hydrocodone Phosphate 675mgs Hydrocodone Tartrate 675mgs Hydromorphone 360mgs Ketobemidone 450mgs Levorphanol Tartrate 135mgs Mazindol 45mgs Mecloqualone 4500mgs Medicinal Opium 1800mgs Mephentermine Sulphate 2700mgs Meprobamate 3600mgs Methadone Hydrochloride Ampoules ) Methadone Hydrochloride Linctus ) 500mgs* Methadone Hydrochloride Tablets ) * If patient is carrying more than 2000mgs, we require confirmation of travel from doctor i.e. he has seen air tickets Methadyl Acetate 500mgs Methaqualone 4500mgs Methaqualone Hydrochloride 4500mgs Methylamphetamine 900mgs Methylamphetamine Hydrochloride 900mgs Methylamphetamine Saccharate 900mgs Ritalin/Methylphenidate Hydrochloride 900mgs Methylphenobarbitone 9000mgs Methyprylone 6000mgs Metopon 1350mgs Morphine Hydrochloride 1200mgs Morphine Sulphate 1200mgs Morphine Tartrate 1200mgs Norpipanone Hydrochloride 270mgs Oxycodone Hydrochloride 900mgs Oxycodone Pectinate 900mgs Oxycontin – treat as Oxycodone 900mgs Oxymorphone Hydrochloride 450mgs Pentazocine Hydrochloride 9000mgs Pentazocine Lactate 5400mgs Pethidine Hydrochloride 2250mgs Phenadoxone 2250mgs 2 Phenazocine 450mgs Phendimetrazine Tartrate 3200mgs Phenmetrazine Hydrochloride 1250mgs Phentermine 450mgs Piminodine Esylate 4500mgs Pipradol Hydrochloride 90mgs Piritramide 3600mgs Piritramide Hydrogen Tartrate 3600mgs Propiram Fumerate 2250mgs Temazepam 900mgs Thebacon Hydrochloride 225mgs Tilidate Hydrochloride 6000mgs Trimeperidine Hydrochloride 2250mgs The following 5, 5-disubstituted Barbituric Acids: Allobarbitone 3000mgs Amylobarbitone 9000mgs Amylobarbitone Sodium 9000mgs Aprobarbitone 7500mgs Barbitone 9000mgs Barbitone Sodium 9000mgs Butalbital 6000mgs Butallylonal 9000mgs Butobarbitone 4500mgs Cyclobarbitone 6000mgs Cyclobarbitone Calcium 6000mgs Cyclopentobarbitone 3000mgs Heptabarbitone 6000mgs Ibomal 6000mgs Nealbarbitone 3000mgs Pentobarbitone 3000mgs Pentobarbitone Calcium 3000mgs Pentobarbitone Sodium 3000mgs Phenobarbitone 2700mgs Phenobarbitone Sodium 12000mgs Phenylmethylbarbituric Acid 6000mgs Probarbitone Sodium 22500mgs Probarbitone Calcium 22500mgs Proxibarbal 9000mgs Quinalbarbitone 3000mgs Quinalbarbitone 3000mgs Secbutobarbitone 1800mgs Secbutobarbitone Sodium 1800mgs Talbutal 1800mgs Vinbarbitone 3000mgs Vinbarbitone Sodium 3000mgs Vinylbitone 3000mgs 3 .
Load more

Recommended publications
  • Pangaea Puzzle Cutouts
    Pangaea puzzle cutouts FAQS Grade 2 3d shapes worksheet free online games for boys "choose displayed name" Rachel steele siterip Pangaea puzzle cutouts cursive converter Pangaea puzzle cutouts Pangaea puzzle cutouts bubble shooter unblocked at school Pangaea puzzle cutouts String gimp patterns Global Why do people have basements in illinoisa aa aaa aaaa aaacn aaah aaai aaas aab aabb aac aacc aace aachen aacom aacs aacsb aad aadvantage aae aaf aafp aag aah aai aaj aal aalborg aalib aaliyah aall aalto aam. puzzle pieces. Discuss what might explain this fit. Point out that millions of years ago the continents were joined together in one supercontinent called Pangaea. Using some of the same evidence that scientists use, they will reconstruct this supercontinent. Exploration 2. Have students work in pairs. Distribute the materials to each pair. ' '' ''' - -- --- ---- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----. read more Creative Pangaea puzzle cutoutsvaMental health and addiction disabilities face. 40 Application Requirements Notice Methods21A. Educators know best what they need to use of existing copyrighted culture to construct their. Akuammigine Adrenorphin Amidorphin Casomorphin DADLE DALDA DAMGO Dermenkephalin Dermorphin Deltorphin DPDPE Dynorphin. The nitrogen morphine derivatives as is codeine methobromide and heterocodeine which is a drug six times read more Unlimited Blister rash earspangea animation for TEENs pangaea ultima animation map pangea with 500 x 539 · 161 kB · jpeg Pangea Activity Cut Out Printable Pangea Puzzle Worksheet . 1 apr 2020. Students will use evidence to connect the continents like a puzzle. to represent the globe and then cut out the landmasses with scissors. students will create a version of Pangaea and glue or tape it inside the large.
    [Show full text]
  • Minnesota Statutes 1979 Supplement
    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
    US 2004O224012A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn et al. (43) Pub. Date: Nov. 11, 2004 (54) TOPICAL APPLICATION AND METHODS Related U.S. Application Data FOR ADMINISTRATION OF ACTIVE AGENTS USING LIPOSOME MACRO-BEADS (63) Continuation-in-part of application No. 10/264,205, filed on Oct. 3, 2002. (76) Inventors: Pichit Suvanprakorn, Bangkok (TH); (60) Provisional application No. 60/327,643, filed on Oct. Tanusin Ploysangam, Bangkok (TH); 5, 2001. Lerson Tanasugarn, Bangkok (TH); Suwalee Chandrkrachang, Bangkok Publication Classification (TH); Nardo Zaias, Miami Beach, FL (US) (51) Int. CI.7. A61K 9/127; A61K 9/14 (52) U.S. Cl. ............................................ 424/450; 424/489 Correspondence Address: (57) ABSTRACT Eric G. Masamori 6520 Ridgewood Drive A topical application and methods for administration of Castro Valley, CA 94.552 (US) active agents encapsulated within non-permeable macro beads to enable a wider range of delivery vehicles, to provide longer product shelf-life, to allow multiple active (21) Appl. No.: 10/864,149 agents within the composition, to allow the controlled use of the active agents, to provide protected and designable release features and to provide visual inspection for damage (22) Filed: Jun. 9, 2004 and inconsistency. US 2004/0224012 A1 Nov. 11, 2004 TOPCAL APPLICATION AND METHODS FOR 0006 Various limitations on the shelf-life and use of ADMINISTRATION OF ACTIVE AGENTS USING liposome compounds exist due to the relatively fragile LPOSOME MACRO-BEADS nature of liposomes. Major problems encountered during liposome drug Storage in vesicular Suspension are the chemi CROSS REFERENCE TO OTHER cal alterations of the lipoSome compounds, Such as phos APPLICATIONS pholipids, cholesterols, ceramides, leading to potentially toxic degradation of the products, leakage of the drug from 0001) This application claims the benefit of U.S.
    [Show full text]
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (As of 10 January 2019 )
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (as of 10 January 2019 ) Afghanistan Cannabis 50 Codeine 50 000 Cannabis resin 1 Dextropropoxyphene 10 000 Coca leaf 1 Diphenoxylate 5 000 Cocaine 15 Fentanyl 1 Codeine 650 000 Methadone 20 000 Codeine -N-oxide 1 Morphine 8 000 Dextromoramide 1 Pethidine 90 000 Dextropropoxyphene 200 000 Pholcodine 40 000 Difenoxin 1 Albania Dihydrocodeine 1 Cocaine 1 Diphenoxylate 1 Codeine 1 189 000 Dipipanone 1 Fentanyl 300 Ecgonine 2 Heroin 1 Ethylmorphine 1 Methadone 7 000 Etorphine 1 Morphine 7 800 Fentanyl 17 000 Oxycodone 2 000 Heroin 1 Pethidine 2 700 Hydrocodone 10 000 Pholcodine 1 500 Hydromorphone 4 000 Remifentanil 9 Ketobemidone 1 Sufentanil 2 Levorphanol 1 Algeria Methadone 100 000 Alfentanil 350 Morphine 1 550 000 Codeine 2 500 000 Morphine -N-oxide 1 Etorphine 1 Nicomorphine 1 Fentanyl 500 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba* Methadone 2 000
    [Show full text]
  • Best Bets from the Manchester Royal Infirmary Edited by K Mackway-Jones
    247 BEST EVIDENCE TOPIC REPORTS Emerg Med J: first published as 10.1136/emj.19.3.248 on 1 May 2002. Downloaded from Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary Edited by K Mackway-Jones Clinical scenario Best evidence topic reports (BETs) summarise the evidence A 23 year old woman attends an emergency department hav- pertaining to particular clinical questions. They are not ing taken sixty 500 mg paracetamol tablets. Her four hour systematic reviews, but rather contain the best (highest paracetamol levels are above the treatment line. She does not level) evidence that can be practically obtained by busy want to be treated with intravenous therapy. You wonder practising clinicians. The search strategies used to find the whether oral antidote is as effective. best evidence are reported in detail in order to allow clinicians to update searches whenever necessary. The BETs published below were first reported at the Critical Three part question Appraisal Journal Club at the Manchester Royal Infirmary.1 In [patients who need an antidote for paracetamol overdose] Each BET has been constructed in the four stages that have is [intravenous therapy better than oral therapy] at [prevent- been described elsewhere.2 The BETs shown here together ing liver damage and death]? with those published previously and those currently under construction can be seen at http://www.bestbets.org.3 Six Search strategy BETs are included in this issue of the journal. Medline 1966 to 12/01 using the OVID interface. [exp acetyl-
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Narcotic Drugs for 2018 (Total of Estimates in Grams Before Adjustment to Stocks) Tableau A
    Table A. Estimated world requirements of narcotic drugs for 2018 (Total of estimates in grams before adjustment to stocks) Tableau A. Évaluations des besoins du monde en stupéfiants pour 2018 (Total des évaluations en grammes avant ajustement aux stocks) Cuadro A. Previsiones de las necesidades mundiales de estupefacientes para 2018 (Total de las previsiones en gramos antes del ajuste a las existencias) (For the explanatory notes to this table, see page 272. — Pour les notes explicatives à ce tableau, voir page 272. — Véanse las notas explicativas sobre este cuadro en la página 273.) Afghanistan* — Afganistán* Morphine — Morfina ............................ 20 Codeine — Codéine — Codeína ................... 20 000 Pethidine — Péthidine — Petidina .................. 300 Dextropropoxyphene — Dextropropoxyphène — Dextropropoxifeno ........................... 7 500 Antigua and Barbuda* — Antigua-et-Barbuda* — Diphenoxylate — Diphénoxylate — Difenoxilato ....... 750 Antigua y Barbuda* Fentanyl — Fentanilo ............................ 2 Cocaine — Cocaïne — Cocaína ................... 9 Methadone — Méthadone — Metadona ............. 15 000 Codeine — Codéine — Codeína ................... 169 Morphine — Morfina ............................ 20 000 Dihydrocodeine — Dihydrocodéine — Dihidrocodeína .. 15 Pethidine — Péthidine — Petidina .................. 12 000 Diphenoxylate — Diphénoxylate — Difenoxilato ....... 28 Pholcodine — Folcodina .......................... 750 Fentanyl — Fentanilo ............................ 1 Morphine — Morfina ...........................
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Partial Agreement in the Social and Public Health Field
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies, and superseding Resolution AP (82) 2) AND APPENDIX I Alphabetical list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 1 July 1988 APPENDIX II Pharmaco-therapeutic classification of medicines appearing in the alphabetical list in Appendix I updated to 1 July 1988 RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (superseding Resolution AP (82) 2) (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands and the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland, Spain and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969, 21 April 1988 and 5 May 1964, respectively, Considering that the aim of the Council of Europe is to achieve greater unity between its members and that this
    [Show full text]
  • Revise Schedule of Controlled Substances. (Public) Sponsors: Senators J
    GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 1 SENATE BILL 347* Short Title: Revise Schedule of Controlled Substances. (Public) Sponsors: Senators J. Davis, McInnis (Primary Sponsors); and Rabin. Referred to: Rules and Operations of the Senate March 22, 2017 1 A BILL TO BE ENTITLED 2 AN ACT REVISING THE SCHEDULE OF CONTROLLED SUBSTANCES TO ADD 3 SYNTHETIC FENTANYLS, DESIGNER HALLUCINOGENICS, SYNTHETIC 4 CANNABINOIDS, SYSTEM DEPRESSANTS, AND OTHER SUBSTANCES. 5 The General Assembly of North Carolina enacts: 6 SECTION 1. This act shall be known and may be cited as the "Synthetic Opioid 7 and Other Dangerous Drug Control Act." 8 SECTION 2. G.S. 90-89 reads as rewritten: 9 "§ 90-89. Schedule I controlled substances. 10 This schedule includes the controlled substances listed or to be listed by whatever official 11 name, common or usual name, chemical name, or trade name designated. In determining that a 12 substance comes within this schedule, the Commission shall find: a high potential for abuse, no 13 currently accepted medical use in the United States, or a lack of accepted safety for use in 14 treatment under medical supervision. The following controlled substances are included in this 15 schedule: 16 (1) Opiates. – Any of the following opiates, including the isomers, esters, ethers, 17 salts and salts of isomers, esters, and ethers, unless specifically excepted, or 18 listed in another schedule, whenever the existence of such isomers, esters, 19 ethers, and salts is possible within the specific chemical designation: 20 a. Acetyl-alpha-methylfentanyl 21 (N[1-(1-methyl-2-phenethyl)-4/y-piperidinyl]-N-phenylacet amide).
    [Show full text]